These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 18514506

  • 21. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
    Li H, Kantoff PW, Ma J, Stampfer MJ, George DJ.
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H, Tsuchiya N, Narita S, Kumazawa T, Horikawa Y, Inoue T, Saito M, Yuasa T, Matsuura S, Satoh S, Ogawa O, Habuchi T.
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.
    Tzanakis N, Gazouli M, Rallis G, Giannopoulos G, Papaconstantinou I, Theodoropoulos G, Pikoulis E, Tsigris C, Karakitsos P, Peros G, Nikiteas N.
    J Surg Oncol; 2006 Dec 01; 94(7):624-30. PubMed ID: 17111394
    [Abstract] [Full Text] [Related]

  • 27. COX-2 gene promoter haplotypes and prostate cancer risk.
    Panguluri RC, Long LO, Chen W, Wang S, Coulibaly A, Ukoli F, Jackson A, Weinrich S, Ahaghotu C, Isaacs W, Kittles RA.
    Carcinogenesis; 2004 Jun 01; 25(6):961-6. PubMed ID: 14754878
    [Abstract] [Full Text] [Related]

  • 28. Resequencing of the vascular endothelial growth factor promoter reveals haplotype structure and functional diversity.
    Radovich M, Hancock BA, Kassem N, Mi D, Skaar TC, Schneider BP.
    Angiogenesis; 2010 Sep 01; 13(3):211-8. PubMed ID: 20552269
    [Abstract] [Full Text] [Related]

  • 29. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):62-6. PubMed ID: 18172253
    [Abstract] [Full Text] [Related]

  • 30. Promoter polymorphisms of the pigment epithelium-derived factor gene are associated with diabetic retinopathy.
    Iizuka H, Awata T, Osaki M, Neda T, Kurihara S, Inoue K, Inukai K, Kabasawa S, Mori K, Yoneya S, Katayama S.
    Biochem Biophys Res Commun; 2007 Sep 21; 361(2):421-6. PubMed ID: 17658465
    [Abstract] [Full Text] [Related]

  • 31. Influence of cytokine gene polymorphisms on the development of prostate cancer.
    McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA, Howell WM.
    Cancer Res; 2002 Jun 15; 62(12):3369-72. PubMed ID: 12067976
    [Abstract] [Full Text] [Related]

  • 32. Estrogen receptor polymorphisms and the risk of endometrial cancer.
    Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ.
    BJOG; 2009 Jul 15; 116(8):1053-61. PubMed ID: 19438492
    [Abstract] [Full Text] [Related]

  • 33. Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.
    Wongpiyabovorn J, Yooyongsatit S, Ruchusatsawat K, Avihingsanon Y, Hirankarn N.
    Tissue Antigens; 2008 Nov 15; 72(5):458-63. PubMed ID: 18937791
    [Abstract] [Full Text] [Related]

  • 34. Vascular endothelial growth factor haplotypes associated with childhood obesity.
    Belo VA, Souza-Costa DC, Luizon MR, Izidoro-Toledo TC, Lanna CM, Pinheiro LC, Tanus-Santos JE.
    DNA Cell Biol; 2011 Sep 15; 30(9):709-14. PubMed ID: 21612402
    [Abstract] [Full Text] [Related]

  • 35. Novel single nucleotide polymorphism of the VEGF gene as a risk predictor for gastroduodenal ulcers.
    Kim YS, Park SW, Kim MH, Jang EJ, Park JS, Park SJ, Baik HW, Chung G, Hahm KB.
    J Gastroenterol Hepatol; 2008 Dec 15; 23 Suppl 2():S131-9. PubMed ID: 19120886
    [Abstract] [Full Text] [Related]

  • 36. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
    Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K.
    J Am Soc Nephrol; 2006 Mar 15; 17(3):823-30. PubMed ID: 16421229
    [Abstract] [Full Text] [Related]

  • 37. A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration.
    Richardson AJ, Islam FM, Guymer RH, Cain M, Baird PN.
    Mol Vis; 2007 Nov 26; 13():2148-52. PubMed ID: 18079689
    [Abstract] [Full Text] [Related]

  • 38. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J, Obeidová H, Lenícek M, Stekrová J, Merta M, Maixnerová D, Vítek L, Viklický O, Tesar V.
    Kidney Blood Press Res; 2008 Nov 26; 31(6):398-403. PubMed ID: 19060482
    [Abstract] [Full Text] [Related]

  • 39. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
    Nagy B, Savli H, Molvarec A, Várkonyi T, Rigó B, Hupuczi P, Rigó J.
    Clin Chim Acta; 2008 Mar 26; 389(1-2):126-31. PubMed ID: 18167313
    [Abstract] [Full Text] [Related]

  • 40. Vascular endothelial growth factor gene polymorphisms as prognostic markers for ocular manifestations in pseudoxanthoma elasticum.
    Zarbock R, Hendig D, Szliska C, Kleesiek K, Götting C.
    Hum Mol Genet; 2009 Sep 01; 18(17):3344-51. PubMed ID: 19483196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.